Akebia Chief Commercial Officer Nicholas Grund to Resign Nov. 6
Nicholas Grund will resign as Akebia Therapeutics’ senior vice president and chief commercial officer effective November 6, 2026, and serve as a consultant through April 30, 2027.
Nicholas Grund will resign as Akebia Therapeutics’ senior vice president and chief commercial officer effective November 6, 2026, and serve as a consultant through April 30, 2027.